NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Surgery Partners, ValueHealth Announce Partnership

Surgery Partners Inc. and ValueHealth LLC have announced a strategic partnership that brings Surgery Partners, a leading independent operator of short-stay surgical facilities, together with ValueHealth, a nationally recognized leader in value-based care. This partnership and the complementary strengths of each company will expand access to consumer-focused, high-value sites of care for patients and physicians.

The partnership will:

  • Accelerate portfolio expansion through an exclusive partnership to develop future de novo ambulatory surgery centers (ASCs), meeting the growing demand for cost-effective, consumer-focused surgical care.
  • Deploy ValueHealth’s suite of comprehensive, value-based surgical programs across Surgery Partners’ current and in-development locations, benefiting patients, physicians, payors and employers who are seeking solutions to reduce escalating surgical costs.
  • Surgery Partners will assume management services and ValueHealth’s interest in three ASCs and four in-development, fully syndicated de novos, primarily supporting orthopedic specialties. Surgery Partners will continue to partner with ValueHealth on strategic assumption of management services and equity interest as part of the ongoing partnership.

Eric Evans, Surgery Partners CEO, said, “This partnership further strengthens our position as the partner of choice for independent physicians and progressive health systems by expanding our reach to new ASCs and introducing the proven value-based care services that ValueHealth has developed. Surgery Partners’ operating platform and leading same-store growth experience, combined with ValueHealth’s high-value specialty programming, creates a differentiated proposition. This allows us to continue to capitalize on the rapid migration of high-acuity surgical cases to the high-quality, short-stay surgical facilities we own and operate.”

“This partnership will be an accelerator to expand access to high-value surgical care, which is in heavy demand by employers and patients,” said Don Bisbee, president and CEO of ValueHealth. “Additionally, our specialty service line programs and employer engagement platform will add significant value for physicians who seek to maintain their independence, allowing them to benefit from the quality outcomes they create while generating savings for those who pay for the care.”

Surgery Partners’ musculoskeletal (MSK) procedure growth combined with ValueHealth’s MSK-focused programming creates a comprehensive suite of services to support a best-in-class patient and clinician experience. In addition to MSK services, this partnership will continue to build the capabilities necessary to capitalize on the migration of cardiology to outpatient settings. This partnership affords both companies with a differentiated offering that is unmatched in the industry.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X